Gut microbiota in acute lung injury/acute respiratory distress syndrome: mechanistic insights and therapeutic opportunities via the gut-lung axis
Frontiers in Cellular and Infection Microbiology · 09.07.2026 · 16
DOI: 10.3389/fcimb.2026.1781229 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.07.2026. Verfasst von Lin Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: LiShizhen College of Traditional Chinese Medicine, Huanggang Normal University, Huanggang, Hubei, China. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Acute Lung Injury, Gastrointestinal Microbiome, Lung. Die Arbeit nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute lung injury (ALI) is a severe clinical syndrome involving inflammatory damage to pulmonary cells, often progressing to acute respiratory distress syndrome (ARDS) with a crude incidence and mortality rate. Despite advances in supportive care, no definitive pharmacological treatment exists. The role of the gut microbiota in immune homeostasis and the gut-lung axis have motivated research into its association with ALI/ARDS. Probiotics, prebiotics, and traditional Chinese herbal medicines have been shown to alleviate ALI/ARDS by modulating gut microbiota. However, the variability among individuals and the complexity of the microbial ecosystem present significant challenges to research and drug development. The integration of multi-omics with artificial intelligence (AI) holds considerable potential for identifying therapeutic targets. This review summarizes the interactions between the gut microbiota and the gut-lung axis in cases of ALI and ARDS. It also discusses the mechanisms through which probiotics, prebiotics, fecal microbiota transplantation (FMT), and traditional Chinese herbal medicines (TCHMs) can intervene, with the aim of developing safer and more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LiShizhen College of Traditional Chinese Medicine, Huanggang Normal University, Huanggang, Hubei, China.
- Hubei Key Laboratory of Germplasm Improvement and Utilization of Dabie Shan Dao-di Herbs (Huanggang Normal University), Huanggang, Hubei, China.
- LiShizhen Culture and Industry Research Center of Traditional Chinese Medicine, Huanggang, Hubei, China.
Zitieren
APA
Zeng, L., Xue, B., Ren, X., Gong, S., & Yan, J. (2026). Gut microbiota in acute lung injury/acute respiratory distress syndrome: mechanistic insights and therapeutic opportunities via the gut-lung axis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1781229
Vancouver
Zeng L, Xue B, Ren X, Gong S, Yan J. Gut microbiota in acute lung injury/acute respiratory distress syndrome: mechanistic insights and therapeutic opportunities via the gut-lung axis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1781229
BibTeX
@article{Zeng2026,
author = {Zeng, Lin and Xue, Bingying and Ren, Xintong and Gong, Shutong and Yan, Jiangtian},
title = {Gut microbiota in acute lung injury/acute respiratory distress syndrome: mechanistic insights and therapeutic opportunities via the gut-lung axis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1781229}
}
EUVIMED